BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18426744)

  • 1. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers.
    Devaraj S; Swarbrick MM; Singh U; Adams-Huet B; Havel PJ; Jialal I
    Am J Clin Pathol; 2008 May; 129(5):815-22. PubMed ID: 18426744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of C-reactive protein to high-molecular-weight adiponectin ratio to predict insulin resistance and metabolic syndrome in Japanese men.
    Saisho Y; Hirose H; Seino Y; Saito I; Itoh H
    J Atheroscler Thromb; 2010 Sep; 17(9):944-52. PubMed ID: 20543521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemerin Ratios to HDL-cholesterol and Adiponectin as Biomarkers of Metabolic Syndrome.
    Shafer-Eggleton J; Adams-Huet B; Jialal I
    Endocr Res; 2020 Nov; 45(4):241-245. PubMed ID: 32835545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.
    Abu-Farha M; Behbehani K; Elkum N
    Cardiovasc Diabetol; 2014 Apr; 13():76. PubMed ID: 24716628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil and monocyte ratios to high-density lipoprotein-cholesterol and adiponectin as biomarkers of nascent metabolic syndrome.
    Jialal I; Jialal G; Adams-Huet B; Ramakrishnan N
    Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome.
    Saltevo J; Vanhala M; Kautiainen H; Kumpusalo E; Laakso M
    Mediators Inflamm; 2007; 2007():93573. PubMed ID: 18288276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the best biomarker for metabolic syndrome diagnosis?
    Falahi E; Khalkhali Rad AH; Roosta S
    Diabetes Metab Syndr; 2015; 9(4):366-72. PubMed ID: 25470629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome.
    Tabak O; Simsek G; Erdenen F; Sozer V; Hasoglu T; Gelisgen R; Altunoglu E; Muderrisoglu C; Senyigit A; Uzun H
    Arch Endocrinol Metab; 2017 Dec; 61(6):515-523. PubMed ID: 28977161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Total and High Molecular Weight Adiponectin with Components of Metabolic Syndrome in Mexican Children.
    Magaña Gomez JA; Moreno-Mascareño D; Angulo Rojo CE; de la Peña GD
    J Clin Res Pediatr Endocrinol; 2020 Jun; 12(2):180-188. PubMed ID: 31552725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin, leptin and high sensitivity C-reactive protein values in obese children - important markers for metabolic syndrome?
    Stroescu RF; Mărginean O; Bizerea T; Gafencu M; Voicu A; Doroș G
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):27-31. PubMed ID: 30530892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons.
    Kawamoto R; Tabara Y; Kohara K; Miki T; Kusunoki T; Takayama S; Abe M; Katoh T; Ohtsuka N
    Cardiovasc Diabetol; 2010 Dec; 9():87. PubMed ID: 21143879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study.
    Tabara Y; Osawa H; Kawamoto R; Tachibana-Iimori R; Yamamoto M; Nakura J; Miki T; Makino H; Kohara K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):715-22. PubMed ID: 18160463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men.
    Matsushita K; Yatsuya H; Tamakoshi K; Wada K; Otsuka R; Takefuji S; Sugiura K; Kondo T; Murohara T; Toyoshima H
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):871-6. PubMed ID: 16456090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Power of Circulatory Metabolic Biomarkers as Metabolic Syndrome Risk Predictors in Community-Dwelling Older Adults in Northwest of England (A Feasibility Study).
    Hassannejad R; Sharrouf H; Haghighatdoost F; Kirk B; Amirabdollahian F
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of C-reactive protein as a risk factor for metabolic syndrome in Indians.
    Mahajan A; Jaiswal A; Tabassum R; Podder A; Ghosh S; Madhu SV; Mathur SK; Tandon N; Bharadwaj D
    Atherosclerosis; 2012 Jan; 220(1):275-81. PubMed ID: 22104116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome.
    Abu-Farha M; Abubaker J; Al-Khairi I; Cherian P; Noronha F; Kavalakatt S; Khadir A; Behbehani K; Alarouj M; Bennakhi A; Elkum N
    Cardiovasc Diabetol; 2016 Feb; 15():25. PubMed ID: 26850725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between High-Sensitivity C-Reactive Protein and Metabolic Syndrome Among Hispanic/Latino Participants of the Hispanic Community Health Study/Study of Latinos.
    Mesa RA; Damas OM; Schneiderman N; Palacio AM; Gallo LC; Talavera GA; Sotres-Alvarez D; Daviglus ML; Pirzada A; Llabre MM; Elfassy T
    Metab Syndr Relat Disord; 2024 Jun; 22(5):327-336. PubMed ID: 38563777
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel biomarker of cardiometabolic pathology in schizophrenia?
    Lee EE; Sears DD; Liu J; Jin H; Tu XM; Eyler LT; Jeste DV
    J Psychiatr Res; 2019 Oct; 117():31-37. PubMed ID: 31276836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women.
    Kawamoto R; Tabara Y; Kohara K; Miki T; Kusunoki T; Takayama S; Abe M; Katoh T; Ohtsuka N
    Endocrine; 2013 Aug; 44(1):132-9. PubMed ID: 23475511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between metabolic syndrome, cardiometabolic risk factors and inflammatory markers in a Tehranian population: the Tehran Lipid and Glucose Study.
    Zarkesh M; Faam B; Daneshpour MS; Azizi F; Hedayati M
    Intern Med; 2012; 51(24):3329-35. PubMed ID: 23257516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.